Is red blood cell in vitro quality and function maintained after S-303 pathogen inactivation treatment?
RBCs treated with S-303 for pathogen reduction had similar in vitro properties to the paired controls and were within transfusion guidelines.
Practices can successfully amalgamate, but only with a group of like-minded general practitioners who are willing to invest time to achieve mutually agreed objectives. Amalgamation is not always appropriate.